Author:
Silva M. F. B.,Aires C. C. P.,Luis P. B. M.,Ruiter J. P. N.,IJlst L.,Duran M.,Wanders R. J. A.,Tavares de Almeida I.
Subject
Genetics (clinical),Genetics
Reference109 articles.
1. Abbott FS, Anari MR (1999) Chemistry and biotransformation. In: Löscher W, ed. Milestones in Drug Therapy-Valproate, Basel: Birkhäuser Verlag, 47–75.
2. Abbott Laboratories (2007) Clinical Pharmacology of Divalproex, Abbott Laboratories Inc., USA: http://www.rxabbott.com/pdf/depakote.pdf .
3. Aires CCP, Ruiter JPN, Luis PBM, et al (2007) Studies on the extra-mitochondrial CoA-ester formation of valproic and Δ4-valproic acids. Biochim Biophys Acta 1771: 533–543.
4. Bailey MJ, Dickinson RG (1996) Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Chem Res Toxicol 9: 659–666.
5. Baillie TA (1988) Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acid. Chem Res Toxicol 1: 195–199.
Cited by
298 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献